rediff.com
Rediff Moneywiz
Home
My Portfolio
My Watchlist
Trends
Market News
Hi Guest
Feedback
Investment Tool
Forex
Indices
Sectors
Mutual Funds
Gainers / Losers
Import Portfolio
All Pages
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Announcements
for
Shilpa Medicare Ltd.
16 May
Board to consider FY22 Results & Dividend on May 23, 2022
16 May
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
02 May
US FDA Inspection Of Shilpa Medicare Limited, Unit VII, Analytical Services Division
26 Apr
Notice Of The National Company Law Tribunal (Tribunal) Convened Meeting Of The Equity Shareholders, Secured Creditors And Trade Creditors Of The Company.
25 Apr
Notice Of The National Company Law Appellate Tribunal (Tribunal) Convened Meeting Of The Equity Shareholders Of The Company.
25 Apr
Shilpa Medicare Limited (SML) Receives Noc From RCGM, Dept. Of Biotechnology For Its Biosimilar Aflibercept - Intimation U/R 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
23 Apr
Submission In Compliance With Regulation 76 Of The Securities And Exchange Board Of India (Depositories And Participants) Regulations, 2018 For Quarter And Financial Year Ended 31 March, 2022.
23 Apr
Disclosure For Non Applicability As Large Entity: SEBI Circular No SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018
23 Apr
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
23 Apr
Sub: Submission In Compliance With Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Financial Year Ended 31 March, 2022.
View announcements for all companies
Next >
Mutual Fund Selector
Find the fund that is right for you